Pay in 4 interest-free payments of $6.24 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
It appears on WADA's Prohibited List under "Hormone and Metabolic Modulators." International regulatory status varies: the European Medicines Agency (EMA) has not approved AOD-9604, and it is banned or restricted in many countries as an unapproved drug product
While some individuals may experience mild digestive side effects such as nausea, bloating, diarrhea, or constipation, these are generally uncommon and typically mild
Route, food, metabolism, and product quality could all change how long the compound remains in the body
When vial-size variants exist, they remain separate because vial strength, concentration, and syringe-unit calculations can differ
Primary mechanism: AOD-9604 works via beta-3 adrenergic receptor upregulation driving lipolysis
The most commonly reported side effects are mild and tend to resolve within the first week of use
